• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAcurx Pharmaceuticals
    Picture of Acurx Pharmaceuticals logo

    ACXP — Acurx Pharmaceuticals News Story

    $1.540.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro CapSucker Stock
    • Market Cap
      $6.62m
    • Enterprise Value
      -$2.64m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACXP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACXP Dividends
    All News

    NASDAQ RESUMED AT 10:20 AM

    Picture of Acurx Pharmaceuticals logoAcurx Pharmaceuticals
    25/06/2021 15:20
    NASDAQ RESUMED  ACXP.O  AT 10:20 AM
    

    Recent news on Acurx Pharmaceuticals

    See all news
    • Acurx Pharmaceuticals Q1 net loss narrows as expenses fall

      12/05/2026 12:39
    • Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update

      20/04/2026 13:01
    • Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

      16/04/2026 21:44
    • Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend

      13/03/2026 11:10
    • Acurx Pharma Q3 net loss narrows to $2 mln

      12/11/2025 12:15

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.